Użytkownik:Ygbood8mnt
UK vendor drug sales have seen a notable uptick, driven by both legitimate pharmaceutical distributors and unregulated online marketplaces. While major wholesalers navigate strict MHRA compliance, smaller vendors leverage encrypted platforms to move prescription meds and controlled substances, often targeting regions with supply gaps. This parallel economy complicates regulatory oversight and raises public health concerns.